MarginsXMarginsX
Home › Markets › EVOTF

Evotec SE (EVOTF)

EVOTF is quoted over the counter, not listed on an exchange. Evotec SE files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · October 5, 2026
$3.33
No trades since Oct 5, 2026; later closes repeat the last quote
1-year return
-58.5%
Market cap
The company also trades on Nasdaq as EVO; this OTC line is another class or a foreign line, so its cap is not computed
P/E and P/S
Needs a market cap · Needs a market cap
On fiscal year to December 31, 2025 (20-F)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerEVOTF, quoted over the counter
SEC CIK0001412558
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressHamburg
Incorporated inGermany

Warning signs

Cash runway
547.1 months
418.5M EUR cash at December 31, 2025
Share count, 1 year
+0.1%
2024-12-31 to 2025-12-31 · +0.5% over 3 years
Going-concern doubt
No
20-F filed April 8, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-04-08
Cash and burn418.5M EUR cash; operating cash flow -2.3M EUR a quarter.Report 2025-12-31
Shares outstanding355,557,814 (2025-12-31); 355,106,912 a year earlier; 353,905,306 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBDO AG Wirtschaftsprüfungsgesellschaft, Berlin, GermanyPCAOB Form AP 2026-05-08
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
788.4M EUR-103.5M EUR-9.2M EUR418.5M EUR276.4M EUR788.4M EUR20-F 2026-04-08
FY 2024
2024-12-31
797.0M EUR-196.1M EUR18.2M EUR306.4M EUR287.6M EUR797.0M EUR20-F 2025-04-17
FY 2023
2023-12-31
781.4M EUR-83.9M EUR36.4M EUR510.9M EUR437.1M EUR781.4M EUR20-F 2025-04-17
FY 2022
2022-12-31
751.4M EUR-175.7M EUR205.8M EUR415.2M EUR329.9M EUR751.4M EUR20-F 2025-04-17
FY 2021
2021-12-31
618.0M EUR215.5M EUR126.6M EUR699.3M EUR362.5M EUR618.0M EUR20-F 2024-08-14
FY 2020
2020-12-31
500.9M EUR6.3M EUR44.7M EUR422.6M EUR15.4M EUR500.9M EUR20-F 2023-05-12
FY 2019
2019-12-31
446.4M EUR38.2M EUR42.2M EUR277.0M EURNo debt tags446.4M EUR20-F 2022-04-26

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in EUR.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42021-11-05
Latest annual report20-F2026-04-08
Latest quarterly / interim6-K2026-11-05

Source: SEC EDGAR submissions feed, 190 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier